Statin myopathy: over-rated and under-treated?

Area of Science:

• Cardiology
• Pharmacology
• Neurology

Background:

• Statins are primary treatments for cardiovascular disease.
• A significant patient subset experiences muscle-related side effects, hindering statin adherence.
• Understanding these side effects is crucial for effective cardiovascular risk management.

Purpose of the Study:

• To review the definition, causes, and management of statin-related muscle disorders.
• To provide an overview of current diagnostic and therapeutic strategies.
• To highlight emerging treatments for cholesterol management.

Main Methods:

• Literature review of consensus group definitions and classifications.
• Analysis of identified mechanisms of statin-induced muscle toxicity.
• Review of therapeutic and clinical investigation pathways and algorithms.

Main Results:

• Statin-related muscle disorders are frequently encountered.
• Identifying secondary causes of muscle disease exacerbated by statins is essential.
• Most cases can be effectively managed through modifications in standard treatment protocols.

Conclusions:

• Statin-induced muscle symptoms require careful evaluation and management.
• Personalized treatment adjustments can often enable continued statin therapy or alternative lipid-lowering strategies.
• Newer non-statin medications offer alternatives for patients with statin intolerance.